News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genor BioPharma of Shanghai May be Acquired and IPO'd


9/12/2013 8:53:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

September 11, 2013 -- Genor BioPharma, a Shanghai biologics drug company, may be sold to a strategic buyer before the end of the month, according to rumors. Genor is a division of the Wison Group, a China conglomerate. There is further speculation that Yunnan Walvax Biotechnology will be the purchaser and that it plans to conduct an IPO for Genor on a US exchange. More details....

Stock Symbol: (SHE: 300142)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES